Compare MATV & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MATV | PSNL |
|---|---|---|
| Founded | 1995 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Paper | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 701.0M | 746.8M |
| IPO Year | 1995 | 2019 |
| Metric | MATV | PSNL |
|---|---|---|
| Price | $14.69 | $8.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $10.00 | ★ $11.17 |
| AVG Volume (30 Days) | 272.7K | ★ 1.4M |
| Earning Date | 02-18-2026 | 02-26-2026 |
| Dividend Yield | ★ 2.75% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,982,500,000.00 | $69,103,000.00 |
| Revenue This Year | $2.62 | N/A |
| Revenue Next Year | $2.26 | $19.41 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.39 | N/A |
| 52 Week Low | $4.34 | $2.83 |
| 52 Week High | $14.95 | $11.50 |
| Indicator | MATV | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 65.96 | 37.39 |
| Support Level | $11.76 | $7.27 |
| Resistance Level | $14.29 | $9.79 |
| Average True Range (ATR) | 0.49 | 0.86 |
| MACD | 0.14 | -0.30 |
| Stochastic Oscillator | 87.36 | 8.51 |
Mativ Holdings Inc is a leader in specialty materials, solving its customers' complex challenges by engineering bold, inventive solutions that connect, protect, and purify the world. The company operates in two segments namely Filtration & advanced Materials focused on filtration media and components, developed films, coating and converting solutions, and extruded mesh products, and (2) Sustainable & Adhesive Solutions (SAS), focused on tapes, labels, liners, specialty paper, packaging and healthcare solutions.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.